- FDA Looks To Grant Full Approval To Pfizer’s COVID-19 Vaccine By Early September: NYT (Benzinga)
- As China’s recovery wobbles, economists expect more policy easing (Reuters)
- Tencent Selloff Shows Deep Scar Tissue in Chinese Markets (Wall Street Journal)
- Lyft Makes Its Move in Race for Profits (Wall Street Journal)
- SoftBank acquires $5bn stake in Swiss drugmaker Roche (Financial Times)
- 6 reasons stocks could surprise to the upside this month despite historically meager returns in August, according to Fundstrat (Business Insider)
- Natural Gas Is Looking Like This Summer’s Hottest Commodity (Wall Street Journal)
- Alibaba Earnings Were Pretty Good. Why the Stock Has Dropped — Just Like Amazon Did. (Barron’s)
- CVS Health raises forecast for year, tops analyst estimates with strong second-quarter sales (CNBC)
- 5 Favorite Dividend-Paying Banks to Buy Now With Q2 Earnings Over (24/7 Wall Street)
- Mortgage rates fall below 3% for first time since February – MBA (Reuters)
- People Have Been Buying Defensive Stocks. (Barron’s)